AMICUS THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price
AMICUS THERAPEUTICS, INC. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price of $12.19 per share as of 2025-12-31, per its 10-K filed 2026-02-20.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice · last filed 2026-02-20
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $12.19.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $11.93.
- 2025-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $11.91.
- 2025-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $11.98.
USD/shares
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price |
|---|---|
| 2025-12-31 | $12.19 10-K · filed 2026-02-20 |
| 2025-09-30 | $11.93 10-Q · filed 2025-11-04 |
| 2025-06-30 | $11.91 10-Q · filed 2025-07-31 |
| 2025-03-31 | $11.98 10-Q · filed 2025-05-01 |
| 2024-12-31 | $11.80 10-K · filed 2025-02-19 |
| 2024-09-30 | $11.75 10-Q · filed 2024-11-06 |
| 2024-06-30 | $11.67 10-Q · filed 2024-08-08 |
| 2024-03-31 | $11.60 10-Q · filed 2024-05-09 |
| 2023-12-31 | $11.26 10-K · filed 2024-02-28 |
| 2023-09-30 | $11.12 10-Q · filed 2023-11-08 |
| 2023-06-30 | $11.02 10-Q · filed 2023-08-08 |
| 2023-03-31 | $10.94 10-Q · filed 2023-05-10 |
| 2022-12-31 | $10.59 10-K · filed 2023-03-01 |
| 2021-12-31 | $9.58 10-K · filed 2022-02-24 |
| 2021-09-30 | $9.42 10-Q · filed 2021-11-09 |
| 2021-06-30 | $9.34 10-Q · filed 2021-08-05 |
CAD/shares
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price |
|---|---|
| 2022-09-30 | 10.49 CAD/shares 10-Q · filed 2022-11-07 |
| 2022-06-30 | 10.38 CAD/shares 10-Q · filed 2022-08-04 |
| 2022-03-31 | 10.20 CAD/shares 10-Q · filed 2022-05-10 |